Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to UMass, Alnylam, DuPont, and more


Title: Compositions for RNA Interference and Methods of Use Thereof

Patent Number: 8,729,036

Filed: Aug. 7, 2003

Lead Inventor: Phillip Zamore, University of Massachusetts

Title: Method and Medicament for Inhibiting the Expression of a Given Gene

Patent Number: 8,729,037

Filed: Oct. 31, 2007

Lead Inventor: Roland Kreutzer, Alnylam Pharmaceuticals

Title: Downregulation of the Gene Expression by Means of Nucleic Acid-loaded Virus-like Particles

Patent Number: 8,729,038

Filed: Sept. 12, 2008

Lead Inventor: Jens Gruber, University of Amsterdam

Title: Compositions and Methods for Treating Hepatic Neoplasia

Patent Number: 8,729,041

Filed: Dec. 2, 2009

Lead Inventor: Joshua Mendell, Johns Hopkins University

Title: Supercoiled Minivectors for Gene Therapy Applications

Patent Number: 8,729,044

Filed: Oct. 15, 2010

Lead Inventor: Lynn Zechiedrich, Baylor College of Medicine

Title: Compositions and Methods for Short Interfering Nucleic Acid Inhibition of Nav1.8

Patent Number: 8,729,045

Filed: Oct. 16, 2012

Lead Inventor: Sameer Goregaoker, Merck

Title: Antisense Oligonucleotides for Inhibition of microRNA-21

Patent Number: 8,729,250

Filed: March 8, 2012

Lead Inventor: Joacim Elmen, Santaris Pharma

Title: Gene Silencing

Patent Number: 8,729,339

Filed: Dec. 18, 2007

Inventor: Milo Aukerman, DuPont